SAMSUNG BIOLOGICS

ISIN KR7207940008

WKN A2AUB1

Market cap (in EUR)

44,172 m

Country

South Korea

Sector

Healthcare

Dividend yield

0.00%

Overview

Description

SAMSUNG BIOLOGICS Co., Ltd. engages in the provision of contract development and manufacturing organization (CDMO) services for pharmaceutical products. It operates through the CDMO and Biopharmaceutical Development and Commercialization business divisions. The CDMO division provides development services from cell line development to early clinical trials, including cell line development, processes, formulations, and analysis methods. The Biopharmaceutical Development and Commercialization division focuses on the development and commercialization of biosimilars and is conducting research and development on various disease fields such as autoimmune diseases, cancer diseases, ophthalmic diseases, and blood diseases. The company was founded on April 22, 2011 and is headquartered in Incheon, South Korea.

Show more Show less

Healthcare Healthcare Services Outsourced Development and Manufacturing Services South Korea

Financials

Key metrics

Market capitalisation, EUR	44,172 m
EPS, EUR	25.37
P/B ratio	9.1
P/E ratio	36.5
Dividend yield	0.00%

Income statement (2025)

Revenue, EUR	2,843 m
Net income, EUR	1,007 m
Profit margin	35.43%

What ETF is SAMSUNG BIOLOGICS in?

There are 20 ETFs which contain SAMSUNG BIOLOGICS. All of these ETFs are listed in the table below. The ETF with the largest weighting of SAMSUNG BIOLOGICS is the JPMorgan Global Emerging Markets Research Enhanced Index Equity SRI Paris Aligned Active UCITS ETF USD (dist).

ETF	Weight	Investment focus	Fund size (in m EUR)
iShares MSCI AC Far East ex-Japan UCITS ETF	0.10%	Equity Asia Pacific	1,656
Vanguard FTSE Developed Asia Pacific ex Japan UCITS ETF Distributing	0.19%	Equity Asia Pacific	1,749
JPMorgan Global Emerging Markets Research Enhanced Index Equity SRI Paris Aligned Active UCITS ETF USD (dist)	0.45%	Equity Emerging Markets Social/Environmental Climate Change	8
iShares MSCI ACWI UCITS ETF USD (Acc)	0.01%	Equity World	31,066
Vanguard ESG Developed Asia Pacific All Cap UCITS ETF (USD) Distributing	0.10%	Equity Asia Pacific Social/Environmental	55
UBS Core MSCI EM UCITS ETF USD dis	0.09%	Equity Emerging Markets	2,810
iShares MSCI EM UCITS ETF (Dist)	0.08%	Equity Emerging Markets	8,746
Vanguard ESG Global All Cap UCITS ETF (USD) Distributing	0.01%	Equity World Social/Environmental	606
iShares MSCI EM IMI Screened UCITS ETF USD (Dist)	0.08%	Equity Emerging Markets Social/Environmental	1,215
iShares MSCI EM CTB Enhanced ESG UCITS ETF USD (Dist)	0.04%	Equity Emerging Markets Social/Environmental	1,036
Vanguard FTSE All-World UCITS ETF (USD) Accumulating	0.01%	Equity World	48,683
Vanguard FTSE Developed World UCITS ETF Distributing	0.01%	Equity World	4,201
JPMorgan AC Asia Pacific ex Japan Research Enhanced Index Equity (ESG) UCITS ETF USD (dist)	0.24%	Equity Asia Pacific Social/Environmental	1
Vanguard FTSE Developed Asia Pacific ex Japan UCITS ETF (USD) Accumulating	0.19%	Equity Asia Pacific	898
Amundi Core MSCI Emerging Markets UCITS ETF EUR Dist	0.09%	Equity Emerging Markets	1,103
Vanguard FTSE Developed World UCITS ETF Acc	0.01%	Equity World	5,935
iShares MSCI Emerging Markets Islamic UCITS ETF	0.22%	Equity Emerging Markets Islamic Investing	688
JPMorgan Global Emerging Markets Research Enhanced Index Equity (ESG) UCITS ETF USD (dist)	0.26%	Equity Emerging Markets Social/Environmental	96
JPMorgan All Country Research Enhanced Index Equity Active UCITS ETF USD (dist)	0.03%	Equity World Social/Environmental	61
Vanguard FTSE All-World UCITS ETF (USD) Distributing	0.01%	Equity World	23,520

Change your settings